+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Merck & Co., Inc. - logo

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

Metastatic Melanoma Therapeutics Market Report 2025 - Product Thumbnail Image

Metastatic Melanoma Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Malabsorption Syndrome Market 2024-2028 - Product Thumbnail Image

Malabsorption Syndrome Market 2024-2028

  • Report
  • July 2024
  • 138 Pages
  • Global
From
From
From
From
Menopause Market Report 2023-2033 - Product Thumbnail Image

Menopause Market Report 2023-2033

  • Report
  • May 2023
  • 253 Pages
  • Global
From
Autoimmune Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2025

  • Report
  • April 2025
  • 500 Pages +
  • Global
From
From
Insulin Pen Market - Product Thumbnail Image

Insulin Pen Market

  • Report
  • February 2024
  • 78 Pages
  • Global
From
Uveal Melanoma - Pipeline Insight, 2025 - Product Thumbnail Image

Uveal Melanoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Renal Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Renal Cell Carcinoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Pediatric Neuroblastoma Treatment Market Report 2025 - Product Thumbnail Image

Pediatric Neuroblastoma Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Loading Indicator